CU6 4.73% $5.09 clarity pharmaceuticals ltd

Research/Valuation, page-208

  1. 18,983 Posts.
    lightbulb Created with Sketch. 5717
    No. The likely reason for why they have seen no DLTs is the SAR-bis-PSMA construct is much better targeted and leaks the CU67 payload less, not anything inherently to do with the use of CU67.

    Unfortunately as you know from another company, once you change anything about the drug you are considered to have a new drug and have to go through the drug development process again.
 
watchlist Created with Sketch. Add CU6 (ASX) to my watchlist
(20min delay)
Last
$5.09
Change
0.230(4.73%)
Mkt cap ! $1.586B
Open High Low Value Volume
$4.95 $5.11 $4.87 $4.562M 911.6K

Buyers (Bids)

No. Vol. Price($)
2 4449 $5.07
 

Sellers (Offers)

Price($) Vol. No.
$5.09 567 1
View Market Depth
Last trade - 16.10pm 26/06/2024 (20 minute delay) ?
CU6 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.